Art

J-GLOBAL ID：201902217509453991   Reference number：19S1685807

Targeted disruption of organic cation transporter 3 (Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells

Author (9)： Zhu, Pengxiang (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Hata, Ryuji (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Cao, Fang (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Sakanaka, Masahiro (Department of Functional Histology, Ehime University Graduate School of Medicine) ,  Ogasawara, Masahito (Department of Pharmacology, Ehime University Graduate School of Medicine) ,  Maeyama, Kazutaka (Department of Pharmacology, Ehime University Graduate School of Medicine) ,  Kameda, Kenji (Integrated Center for Science, Ehime University Graduate School of Medicine) ,  Yamauchi, Kohei (Third Department of Internal Medicine, Iwate Medical University School of Medicine) ,  Schinkel, Alfred H. (Division of Molecular Biology, Netherland Cancer Institute)
Material： Journal of Cerebral Blood Flow and Metabolism
Volume： 32  Issue： 10  Page： 1897-1908  Publication year： 2012 
JST Material Number： SCOPUS  ISSN： 0271-678X  CODEN： JCBMD 
Country of issue： United States (USA)  Language： English (EN)

Terms in the title (1)： OCT3